Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2025 Earnings Call Transcript December 11, 2024
Champions Oncology, Inc. beats earnings expectations. Reported EPS is $0.05, expectations were $0.01.
Operator: Greetings. Welcome to the Champions Oncology Second Quarter Fiscal Year 2025 Earnings Call. At this time, all participants are in a listen only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded. I...
